26 noviembre 2014
An experimental vaccine to prevent Ebola virus disease was well-tolerated and produced immune system responses in all 20 healthy adults who received it in a Phase 1 clinical trial.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/nQTWvTVx_G4/141126171428.htm
